Clin2
NCT04778046Possibly a fitRecruiting

Study lung pressure treatment for people waiting for transplant

Interstitial Lung DiseaseCOPDPulmonary Arterial Hypertension

Part of Lungs & breathing clinical trials.

This Phase 2 trial is for adults with pulmonary hypertension who are on the lung transplant waiting list at Duke. It aims to test whether the study treatment can improve lung pressure and related health outcomes, while using things like MRI to monitor changes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
30 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Be 18 years or older
  • Be on the lung transplant waiting list at Duke University Medical Center
  • Have pulmonary hypertension confirmed by a right-heart catheter test (mPAP > 20 and PVR > 3, with PCWP < 15)
  • Have one of these lung-heart diagnoses: PAH, COPD, or IPF, with the study group depending on test results for precapillary PH
  • Be able and willing to sign consent and follow all study visits and rules
  • Be able to safely do MRI scans (no unsafe metal in body/eyes, able to lie flat, and able to tolerate the scanner)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04991454Recruiting· Phase 2
Xenon mri to image lung blood flow in pulmonary hypertension

This trial uses a special MRI scan with xenon gas to take detailed images of how blood moves through your lungs. It aims to see if this imaging can help doctors better understand and manage pulmonary hypertension, which is high blood pressure in the lungs.

Durham, North Carolina
NCT06104228Recruiting· Phase 2
Xenon MRI to detect and track pulmonary hypertension

This trial uses a special MRI scan (using xenon gas) to see how well the lungs are working in people with pulmonary arterial hypertension (PAH). It aims to improve diagnosis and monitoring of PAH from connective tissue disease or unknown cause.

Durham, North Carolina
NCT06351345Recruiting· Phase 2
Xenon imaging study for pulmonary hypertension patients on sotatercept

This trial uses a special imaging technique (xenon MRI) to see how well the lungs are functioning in people with pulmonary arterial hypertension (PAH) who are being treated with the drug sotatercept. It aims to understand if the drug improves lung function.

Durham, North Carolina
NCT01280994Recruiting· Phase 2
Lung MRI test using special gas to measure breathing

This Phase 2 study uses a special type of MRI with inhaled gas to measure how well your lungs work. It may help researchers better understand lung function in healthy people and in people with lung disease.

Durham, North Carolina
NCT06038630Recruiting· Phase 2
Xenon gas MRI study for lung and heart health

This study uses a special MRI scan (Xenon gas imaging) to look at how well your lungs and heart are working. It is for people with certain lung conditions, those getting blood transfusions or phlebotomy, or healthy volunteers.

Durham, North Carolina
NCT04624490Recruiting· Phase 1
Lung function MRI using a special gas in volunteers

This Phase 1 study tests a lung scan that uses a special gas and MRI to measure how well your lungs work. It includes healthy volunteers and people with lung disease to see how well the scan works and how safe it is.

Kansas City, Kansas

Hear when a new Interstitial Lung Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.